AR004950A1 - Nitronas ciclicas, composicion farmaceutica y su uso para la fabricacion de medicamentos - Google Patents

Nitronas ciclicas, composicion farmaceutica y su uso para la fabricacion de medicamentos

Info

Publication number
AR004950A1
AR004950A1 ARP960104278A AR10427896A AR004950A1 AR 004950 A1 AR004950 A1 AR 004950A1 AR P960104278 A ARP960104278 A AR P960104278A AR 10427896 A AR10427896 A AR 10427896A AR 004950 A1 AR004950 A1 AR 004950A1
Authority
AR
Argentina
Prior art keywords
ring
alkyl
hydrogen
group
represented
Prior art date
Application number
ARP960104278A
Other languages
English (en)
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of AR004950A1 publication Critical patent/AR004950A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/20—Spiro-condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/08—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with a hetero atom directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/10—Aza-phenanthrenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Nuevas nitronas ciclicas de la formula (I), donde R1 y R2 son cada uno independientemente respresentados por un alquilo C1-3 o R1 y R2 juntos formanun anillo de alquileno C5-6 o un anillo de la estructura (a); Z representa (CHx)n, donde xy n son independientemente 0 o un numero de 1 a 2; R3 esrepresentado por un substituyente seleccionado entre el grupo consistente en hidrogeno, alquilo C1-4, OH, OAh o O=, y el anillo representado por X es unsubstituyente seleccionado entre elgrup o consistente en:(II), donde el area de sombra obscura representa el lado de union al anillo de nitrona, R4, R5, R6 yR7, son independientemente seleccionados entre el grupo consistente en hidrogeno, alquilo C1-C3, OH o alcoxi C1-3 ysus sale s farmaceuticamenteaceptables, con la condicion de que, cuando R1 y R2 formen juntos un anillo de alquileno C5-6 y n sea 1, entonces R3 no pueda ser hidrogeno. Tambien sedescriben composiciones farmaceuticas que contienen dichas nitronas ysu uso en la prevencion de la lesion tisular por oxidacion de radicales libres.
ARP960104278A 1995-09-11 1996-09-09 Nitronas ciclicas, composicion farmaceutica y su uso para la fabricacion de medicamentos AR004950A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US355195P 1995-09-11 1995-09-11

Publications (1)

Publication Number Publication Date
AR004950A1 true AR004950A1 (es) 1999-04-07

Family

ID=21706397

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960104278A AR004950A1 (es) 1995-09-11 1996-09-09 Nitronas ciclicas, composicion farmaceutica y su uso para la fabricacion de medicamentos

Country Status (21)

Country Link
US (1) US5962469A (es)
EP (1) EP0863878B1 (es)
JP (1) JPH11512427A (es)
KR (1) KR100512675B1 (es)
CN (3) CN1500779A (es)
AR (1) AR004950A1 (es)
AT (2) ATE293604T1 (es)
AU (1) AU701989B2 (es)
CA (1) CA2231812C (es)
DE (2) DE69625701T2 (es)
DK (2) DK0863878T3 (es)
ES (2) ES2239194T3 (es)
HU (1) HUP9803028A3 (es)
IL (1) IL123345A (es)
MX (1) MX9801892A (es)
NO (1) NO311357B1 (es)
NZ (1) NZ316288A (es)
PT (2) PT1288203E (es)
TW (1) TW337520B (es)
WO (1) WO1997010218A1 (es)
ZA (1) ZA967514B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2226999A (en) * 1998-01-16 1999-08-02 Renovis, Inc. Thiophene nitrone compounds
JP2002535334A (ja) * 1999-01-19 2002-10-22 ニューロサーチ、アクティーゼルスカブ 縮合ヘテロ環状化合物及びこれを神経変性疾患の治療に使用する方法
CN100513395C (zh) * 2006-04-17 2009-07-15 中国科学院化学研究所 一种制备多羟基环状硝酮的方法
CN101565453B (zh) * 2008-04-22 2011-12-21 中国科学院化学研究所 具有捕获自由基功能的硝酮类化合物及其制备方法与应用
ES2395803B1 (es) * 2011-08-01 2013-12-19 Consejo Superior De Investigaciones Científicas (Csic) - 80% Quinolilnitronas
US8883857B2 (en) 2012-12-07 2014-11-11 Baylor College Of Medicine Small molecule xanthine oxidase inhibitors and methods of use
US10660851B2 (en) 2015-01-02 2020-05-26 Rxos Medical Polyfunctional radical scavenger hydrogel formulation
CN105985389B (zh) * 2015-03-06 2019-03-19 北京大学 苯乙醇苷类似物及其合成方法和应用
WO2017137402A1 (en) * 2016-02-08 2017-08-17 Lunaphore Technologies Sa Methods of sample cycle multiplexing and in situ imaging

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US35112A (en) * 1862-04-29 Improvement in head-rests for car-seats
US3044930A (en) * 1960-12-08 1962-07-17 Phillips Petroleum Co N-oxides of heterocyclic nitrogen compounds as bird and rodent repellents
US3796715A (en) * 1967-08-30 1974-03-12 Hoffmann La Roche 8-alkoxy-3,4-dihydroisoquinolines
US4123543A (en) * 1971-09-16 1978-10-31 Ab Kabi Derivatives of substituted indoline lactans with effect on the central nervous system
SE368009B (es) * 1971-09-16 1974-06-17 Kabi Ab
US4117144A (en) * 1971-09-16 1978-09-26 Ab Kabi Derivatives of substituted isoindolines with effect on the central nervous system
JPS6363851A (ja) * 1986-09-05 1988-03-22 孫七瓦工業株式会社 瓦の葺設方法
WO1991005552A1 (en) * 1989-10-17 1991-05-02 Oklahoma Medical Research Foundation Method and compositions for inhibition of disorders associated with oxidative damage
WO1992022290A1 (en) * 1991-06-18 1992-12-23 Oklahoma Medical Research Foundation Use of spin trapping for the treatment of diseases associated with oxidation of lipids and proteins
IL103111A (en) * 1991-09-12 1996-07-23 Merrell Dow Pharma Cyclic neutrons, a process for their preparation and pharmaceutical preparations containing them
US5292746A (en) * 1991-09-12 1994-03-08 Merrell Dow Pharmaceuticals Inc. Cyclic nitrones, pharmaceutical compositions thereof and their use in treating shock
US5405967A (en) * 1993-10-22 1995-04-11 Oklahoma Medical Research Foundation Spin-trap molecules 2-trifluoromethyl- of 5,5-dimethyl-1-dyrroline-N-oxide
US5455272A (en) * 1993-10-22 1995-10-03 Oklahoma Medical Research Foundation Spin trap nitronyl hindered phenols
AU8051894A (en) * 1993-10-25 1995-05-22 Oklahoma Medical Research Foundation Novel phosphorus-containing spin-trap compositions
US5488145A (en) * 1993-12-23 1996-01-30 Oklahoma Medical Research Foundation 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceutical free radical traps
US5472983A (en) * 1994-04-14 1995-12-05 Centaur Pharmaceuticals, Inc. Benzamide-containing pharmaceutical compositions

Also Published As

Publication number Publication date
AU6848696A (en) 1997-04-01
DE69634647T2 (de) 2006-03-02
EP0863878A1 (en) 1998-09-16
NZ316288A (en) 2000-01-28
TW337520B (en) 1998-08-01
HUP9803028A2 (hu) 1999-04-28
AU701989B2 (en) 1999-02-11
IL123345A0 (en) 1998-09-24
DK0863878T3 (da) 2003-04-22
DE69634647D1 (de) 2005-05-25
ES2239194T3 (es) 2005-09-16
IL123345A (en) 2003-07-31
CN1500779A (zh) 2004-06-02
MX9801892A (es) 1998-05-31
ZA967514B (en) 1997-03-10
WO1997010218A1 (en) 1997-03-20
NO981054D0 (no) 1998-03-10
ATE230731T1 (de) 2003-01-15
JPH11512427A (ja) 1999-10-26
NO311357B1 (no) 2001-11-19
DE69625701D1 (de) 2003-02-13
KR19990044557A (ko) 1999-06-25
CN1250528C (zh) 2006-04-12
ES2185797T3 (es) 2003-05-01
NO981054L (no) 1998-03-10
CA2231812A1 (en) 1997-03-20
KR100512675B1 (ko) 2006-08-10
US5962469A (en) 1999-10-05
DE69625701T2 (de) 2003-10-02
PT863878E (pt) 2003-04-30
ATE293604T1 (de) 2005-05-15
DK1288203T3 (da) 2005-07-11
CA2231812C (en) 2002-08-06
CN1196050A (zh) 1998-10-14
EP0863878B1 (en) 2003-01-08
PT1288203E (pt) 2005-08-31
HUP9803028A3 (en) 1999-05-28
CN1500787A (zh) 2004-06-02

Similar Documents

Publication Publication Date Title
MX9202328A (es) Composicion farmaceutica local que contiene un compuesto alilamina como el agente activo.
ES2100187T3 (es) Derivados de carboestirilos y composiciones farmaceuticas que los contienen.
ES2175137T3 (es) Derivados de (imidazol-5-il)metil-2-quinolinona como inhibidores de laproteina farnesil-transferasa.
DK0495053T3 (da) Ny linker til bioaktive midler
ATE6507T1 (de) Piperidinderivate, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ES2184326T3 (es) Nuevos compuestos derivados del mentol y su utilizacion como agente refrescante.
ATE87473T1 (de) Arzneimittel zur inhibition von hautfalte.
ES8600210A1 (es) Un procedimiento para la preparacion de nuevos derivados de arilamida
AR004950A1 (es) Nitronas ciclicas, composicion farmaceutica y su uso para la fabricacion de medicamentos
ES451557A1 (es) Un procedimiento de preparacion de una composicion de champuliquido transparente.
SE7611145L (sv) Sett att framstella delta?7215-steroider
AR246509A1 (es) Una cetimina, su preparacion y un agente de entrecruzamiento que la contiene.
DK0984934T3 (da) Hidtil ukendte oralt aktive jern(III)chelateringsmidler
PE23198A1 (es) Nuevos derivados de fenilamidina, procedimiento para su preparacion y su utilizacion como medicamentos
ES2056153T3 (es) Expectorante que comprende un derivado hidroxialquilcisteina.
ES2090066T3 (es) Preparaciones externas que contienen agua y propionato de deprodona.
FI812804L (fi) 2-(1,4-bensodioxan-2-ylalkyl)-imidazoler anvaendbara som antidepressiva laekemedel
KR830004219A (ko) 약리적 활성 펩티드
DK624989D0 (da) Hidtil ukendte forbindelser
ES2032217T3 (es) Nuevos derivados n-(23-vinblastinoil del acido 1-amino-metilfosfonico, sus procedimientos de preparacion y las composiciones farmaceuticas que los contienen.
SE8203053L (sv) Cysteinderivat i form av disulfid
ES2039719T3 (es) Procedimiento para preparar un agente terapeutico para el tratamiento de la enfermedad de ulcera peptica.
ES2117003T3 (es) Derivados oligopeptidicos de hipoxantina dotados de actividad inmunomoduladora, y composiciones farmaceuticas que los contienen.
NO983527L (no) Dihydrobenzofuran og relaterte forbindelser anvendelig som anti-inflammatoriske midler
ES382051A1 (es) Procedimiento para la preparacion de nuevos esteres y ami- das de acido n-((3-trifluorometilfenil) - antraniloil) - glicolico.

Legal Events

Date Code Title Description
FC Refusal